The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema

医学 氟辛醇酮 视力 眼压 眼科 前瞻性队列研究 植入 糖尿病性视网膜病变 皮质类固醇 观察研究 外科 糖尿病 内科学 内分泌学
作者
Pauline T. Merrill,Nancy M. Holekamp,Daniel Roth,Jonathan Kasper,Ruben Grigorian
出处
期刊:American Journal of Ophthalmology [Elsevier BV]
卷期号:248: 16-23 被引量:5
标识
DOI:10.1016/j.ajo.2022.09.017
摘要

To assess treatment burden in patients with diabetic macular edema (DME) after the 0.19-mg fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN).Prospective and retrospective analyses of a 36-month, phase 4, open-label, observational study.Setting: Multicenter.Included patients had DME and previously received corticosteroid treatment without a clinically significant rise in intraocular pressure (IOP) (N = 202 eyes in 159 patients). Patients were not randomized.Prospective, observational treatment burden data were analyzed for their relationship to safety and functional efficacy outcomes across 36 months.Outcomes included the mean number of yearly treatments, supplemental-free probability over time, best-corrected visual acuity, and monitoring of IOP-related events.Over 36 months, the mean number of yearly treatments decreased from 3.5 before FAc to 1.7 after FAc; at 36 months, 68.3% of patients required 0 to 2 treatments per year. After FAc, the percentage of eyes requiring supplemental therapy decreased vs before FAc (P < .0001 for each). Through 36 months, 25% of FAc-treated eyes did not require supplemental treatment. At 36 months, mean best-corrected visual acuity increased by 4.5 letters vs a decline of 6.4 letters in the 36 months before FAc. IOP elevations >25 mm Hg occurred in 18.2% of eyes that did not receive supplemental treatment after FAc vs 27.2% of eyes that received supplemental treatments, which included additional intraocular steroids.Over 36 months, the FAc implant is associated with improved visual outcomes and better disease control as measured by a significant reduction in yearly treatment burden in patients with DME.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
愉快的新波完成签到,获得积分10
刚刚
2秒前
2秒前
2秒前
2秒前
完美世界应助zlttt采纳,获得10
4秒前
momo发布了新的文献求助10
6秒前
漫山完成签到,获得积分10
6秒前
量子星尘发布了新的文献求助10
6秒前
7秒前
8秒前
9秒前
阿斗发布了新的文献求助10
10秒前
10秒前
踏实的火龙果完成签到 ,获得积分20
10秒前
健忘白完成签到,获得积分10
12秒前
ding应助liang采纳,获得30
13秒前
厉害tt完成签到,获得积分10
13秒前
13秒前
ding应助momo采纳,获得10
13秒前
在水一方应助吧啦吧啦采纳,获得10
13秒前
踏实的火龙果关注了科研通微信公众号
14秒前
维尼发布了新的文献求助20
15秒前
文档发布了新的文献求助10
15秒前
Rondab应助千余采纳,获得10
19秒前
19秒前
taowang发布了新的文献求助30
19秒前
一支笔画天下完成签到 ,获得积分10
19秒前
20秒前
CL完成签到 ,获得积分10
21秒前
hnlgdx完成签到,获得积分20
21秒前
Dotson发布了新的文献求助20
21秒前
出门见喜发布了新的文献求助10
23秒前
丁老三完成签到 ,获得积分10
24秒前
gky完成签到,获得积分10
25秒前
27秒前
嘻哈完成签到,获得积分10
28秒前
火力全开发布了新的文献求助10
29秒前
taowang完成签到,获得积分10
33秒前
地表飞猪应助科研通管家采纳,获得10
33秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989297
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253893
捐赠科研通 3270097
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809158